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M ost patients with follicular lymphoma have an indolent clinical course [1 , 2].  However,  devel-
opment of a high-grade,  aggressive non-Hodgkin lym-
phoma occurs in some follicular lymphoma patients via 
a process called histologic transformation [3].  Because 
histologic transformation necessitates prompt initiation 
of treatment,  the diagnosis of histologic transformation 
is crucial in the management of follicular lymphoma.
We herein report the case of a follicular lymphoma 
patient who had histologic transformation to diffuse 
large B-cell lymphoma (DLBCL).  Of note,  histologic 
transformation was detected during colonoscopy as a 
newly emerged rectal lesion.  Endoscopic features of the 
colorectal lesions of follicular lymphoma and DLBCL 
are discussed later in this report.
Case Presentation
A 69-year-old Japanese woman visited her family 
clinic with abdominal pain.  Computed tomography 
(CT) scanning revealed intra-abdominal and inguinal 
lymphadenopathies.  She was referred to our hospital 
for further investigation and treatment.  A diagnosis of 
follicular lymphoma (grade 1,  stage IIA) was made by 
biopsy examination of the inguinal lymph nodes.  Six 
cycles of cyclophosphamide,  doxorubicin,  vincristine,  
prednisone,  and rituximab resulted in a decrease of the 
lymphadenopathies.  However,  tracer uptake persisted 
in the mesenteric lymph nodes on fluorodeoxyglucose- 
positron emission tomography (FDG-PET).  At 71 years 
of age her mesenteric lymph nodes were enlarged again,  
and she was treated with 6 cycles of bendamustine and 
rituximab.  Her right neck lymph nodes were still avid 
for FDG-PET tracer after bendamustine and rituximab 
treatment.  Thus,  rituximab monotherapy,  spaced 3 to 
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4 months apart,  i.e.,  rituximab maintenance,  was 
started at 72 years of age.  Colonoscopy performed at 
72 years of age revealed an adenoma in the rectosig-
moid junction,  while there was no lymphoma involve-
ment in the colorectum.
At 77 years of age,  the patient experienced persistent 
abdominal pain.  Physical examination revealed no 
abnormalities,  and there was no evidence of hepato-
splenomegaly or peripheral lymphadenopathy.  
Laboratory tests showed slightly elevated values for 
lactate dehydrogenase (237 U/L;  normal range: 124-
222 U/L),  aspartate aminotransferase (38 U/L),  alkaline 
phosphatase (394 U/L),  urea nitrogen (28.1 mg/dL),  
creatinine (0.82 mg/dL),  and uremic acid (6.6 mg/dL).  
Her hemoglobin,  serum calcium,  and soluble interleu-
kin 2-recepter levels were within the normal ranges.  
Computed tomography revealed intra-abdominal 
lymphadenopathies (Fig . 1A) and tracer accumulation 
was observed on FDG-PET (Fig . 1B).  Therefore,  lym-
phoma progression was considered to be the cause of 
her abdominal pain.
Colonoscopy revealed an elevated lesion in the rec-
tum,  which presented as 2 humps with subepithelial 
tumor-like appearance (Fig . 2A).  Linked color imaging 
observation (Fig . 2B) and indigo carmine dye spraying 
(Fig . 2C) emphasized the lesion’s reddish color.  
Magnifying observation with blue laser imaging showed 
dilated microvessels (Fig . 2D) and erosions (Fig . 2E) on 
the surface.  Because the colorectum had been intact on 
colonoscopy performed 5 years previously,  we sus-
pected the lesion to be a lymphomatous rectal involve-
ment.  A biopsy showed dense infiltration of atypical 
lymphoid cells of medium to large size in the intersti-
tium (Fig . 3A).  Immunostaining revealed that the lym-
phoid cells were positive for CD20 (Fig . 3B),  CD10 
(Fig . 3C),  and BCL2 (Fig . 3D),  and were negative for 
CD3 (Fig . 3E) and CD5 (Fig . 3F).  Cells were diffusely 
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Fig. 1　 Radiological images.  Computed tomography revealed 
intra-abdominal lymphadenopathies (A).  Fluorodeoxyglucose-





Fig. 2　 Colonoscopy images.  An elevated lesion is observed in the rectum (A).  Linked color imaging observation (B) and indigo carmine 
dye spraying (C) emphasized the lesionʼs reddish color.  Magnifying observation with blue laser imaging revealed dilated microvessels (D) 
and erosions (E).
positive for Ki-67 (Fig . 3G).  Therefore,  we diagnosed 
the patient with histologic transformation of follicular 
lymphoma to DLBCL.  Salvage chemotherapy with 6 
cycles of bendamustine and rituximab resulted in the 
disappearance of metabolic tumor activity in lym-
phoma lesions on FDG-PET.
Discussion
In the patient presented in this case report,  histo-
logic transformation of follicular lymphoma to DLBCL 
occurred during maintenance therapy with rituximab.  
Histologic transformation is generally defined as an 
increase in the proportion of large cells infiltrating the 
lymph nodes diffusely and leading to effacement of the 
follicular architecture [3-5].  Clinically,  DLBCL is the 
most commonly observed histologic transformation of 
follicular lymphoma.  The annual incidence of histo-
logic transformation of grade 1,  2,  and 3a follicular 
lymphoma into an aggressive lymphoma has been esti-
mated at 1% to 2% [6].  An open-label,  multicenter,  
international,  randomized phase III study of 2 years of 
rituximab maintenance after first-line immunochemo-
therapy (PRIMA study) revealed that rituximab mainte-
nance provided a significant long-term progression-free 
survival in follicular lymphoma patients,  whereas such 
maintenance was not associated with a difference in 
overall survival [7 , 8].  The prevalence of and time to 
histologic transformation were not different between 
patients with and without rituximab maintenance.  
Thus,  the evolution of follicular lymphoma to a clini-
cally aggressive lymphoma can occur even during 
maintenance therapy with rituximab,  as observed in our 
patient.
In the present case,  transformation to DLBCL was 
pathologically confirmed by endoscopic biopsy of the 
rectal lesion.  In our earlier work,  we investigated the 
endoscopic features of colorectal lesions in 12 patients 
with follicular lymphoma [9 , 10].  Macroscopic appear-
ance of colorectal follicular lymphoma was classified as 
papular (n = 4),  polypoid (n = 4),  and flat elevated 
lesions (n = 4).  We also reviewed 8 previously reported 
cases in which detailed morphological characteristics of 
colorectal involvement with follicular lymphoma were 
described [11-18].  Among these cases,  the macro-
scopic appearance of the colorectal lesions could be 
categorized into papular (n = 1),  polypoid (n = 5),  and 
flat elevated (n = 1),  with ulcerative tumor occurring in 
only one patient with grade 3a follicular lymphoma 
[19].  Apart from the latter exceptional case [19],  no 
erosions or ulcers were found in the previously reported 
cases.  Therefore,  we speculate that follicular lymphoma,  
particularly that of grade 1-2,  presents as elevated 
lesions without erosions or ulcers in the colorectum.
Colorectal lesions of DLBCL exhibit a diverse range 
of morphologies,  including ulcers [20 , 21],  large 
masses with or without ulceration [22-24],  nodular 
masses [25],  and colitis-like changes [26].  Maeshima et 
al.  investigated the clinicopathological characteristics 
of 126 patients with DLBCL involving the small and 










Fig. 3　 Pathology images.  A biopsy shows dense infiltration of atypical lymphoid cells (A).  The lymphoid cells are positive for CD20 (B),  
CD10 (C),  and BCL2 (D), and are negative for CD3 (E) and CD5 (F).  Cells are diffusely positive for Ki-67 (G).
large intestines [27].  They reported that rectal lesions 
were observed as ulcerated (n = 1,  17%),  nodular 
(n = 2,  33%),  multiple polyposis (n = 2,  33%),  and flat 
elevated (n = 1,  17%).  Ileocecal lesions of DLBCL most 
frequently presented as ulcerated (n = 31,  56%),  fol-
lowed by nodular (n = 22,  39%),  and flat elevated 
lesions (n = 3,  5%).  In the colon,  ulcerated (n = 8,  
73%),  nodular (n = 2,  18%),  and flat elevated lesions 
(n = 1,  9%) were observed.  Thus,  ulcerative lesions are 
predominant features of DLBCL occurring in the large 
intestine,  while follicular lymphoma lesions in the large 
intestine generally lack erosions or ulcers.  We speculate 
that histologic transformation should be considered 
when colorectal lesions with erosions and/or ulcers 
emerge in patients with follicular lymphoma,  as 
observed in the present patient.
It was also noteworthy that the rectal lesion was not 
detected on FDG-PET but was identified during colo-
noscopy.  FDG-PET is generally recommended for stag-
ing of DLBCL patients because of its superior sensitivity 
for the detection of nodal and extra-nodal lymphoma 
involvement [28 , 29].  However,  because the tracer 
concentration corresponds to the regional glucose 
uptake,  it is likely that small lesions cannot be detected.  
Another hypothesis is that treatment for follicular lym-
phoma resulted in the false-negative FDG-PET results.  
It has been reported that not a few patients with DLBCL 
show false-negative results for relapse after chemother-
apy [29 , 30].  Moreover,  we previously investigated 
FDG-PET results in 41 patients with follicular lym-
phoma,  and found that false-negative tracer uptake was 
detected in 24 patients (58.5%) [31].  In this context,  we 
consider that endoscopic examinations should be per-
formed in follicular lymphoma patients irrespective of 
FDG-PET results,  in order to detect histologic trans-
formation as well as lymphoma progression to the gas-
trointestinal tract.
In conclusion,  in our patient with follicular lym-
phoma,  histologic transformation to DLBCL was iden-
tified as a rectal lesion with erosions.  Although such a 
manifestation is considered to be infrequent,  the clini-
cal course of our patient underscores the importance of 
endoscopy examinations and biopsy of newly emerged 
gastrointestinal lesions,  particularly those with ero-
sions,  for prompt diagnosis of histologic transforma-
tion.
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